What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas

Australian and New Zealand Journal of Psychiatry

Volumn 30, Issue 2, 1996, Pages 195-209

  Velakoulis, Dennis ^a   Pantelis, Christos ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Cognitive Neuropsychiatry Unit ^*

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR;

BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN METABOLISM; FRONTAL LOBE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RECEPTOR DENSITY; SCHIZOPHRENIA; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; TEMPORAL LOBE;

EID: 0029899546     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679609076095     Document Type: Short Survey

References (111)

1. Buchsbaum MS. The frontal lobes, basal ganglia, temporal lobes as sites for schizophrenia. Schizophrenia Bulletin 1990;16:379-390.
2. Pantelis C, Barnes TRE, Nelson HE. Is the concept of frontal-subcortical dementia relevant to schizophrenia? British Journal of Psychiatry 1992; 160:442-460.
3. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. American Journal of Psychiatry 1992; 149:890-897.
4. Andreasen N. Brain imaging: applications in psychiatry. Washington DC: American Psychiatric Press, 1989.
5. Geaney DP, Ellis PM, Shepstone BJ, Cowen PJ. Single photon emission computerized tomography: assessment of cerebral dopamine D2 receptor blockade in schizophrenia. Biological Psychiatry 1992; 32:293-295.
6. Raichle M, Grubb R, Gado M, Eichung J, Ter-Pergossian M. Correlation between regional cerebral blood flow and oxidative metabolism. Archives of Neurology 1976; 33:523-526.
7. Baron G, Lebrun-Grandie P, Collard P, Crouzel C, Mestelan G, Bousser M. Non invasive measurement of blood flow, oxygen consumption and glucose utilization in the same brain regions in man by positron emission tomography. Journal of Nuclear Medicine 1982; 23:391-399.
8. Hoyer S, Oesterreich K. Blood flow and oxidative metabolism of the brain in the course of acute schizophenia. Acta Neurologica Scandinavica Supplementum 1977; 64:534-535.
9. Geaney D, Abou-Saleh M. The use and applications of single photon emission computerised tomography in dementia. British Journal of Psychiatry 1990; 157:S66-S75.
10. Lebrun-Grandie P, Baron J, Soussaline F, Loc'h C, Sastre J, Bousser M. Coupling between regional blood flow and oxygen utilization in the normal human brain: a study with positron tomography and oxygen 15. Archives of Neurology 1983; 40:230-236.
11. Mathew RJ, Wilson WH, Tant SR. Determinants of resting regional blood flow in normal subjects. Biological Psychiatry 1986; 21:907-914.
12. Macs M, Dierckx R, Meltzer H, Ingels M, Schotte C, Vandewoude M, Calabrese J, Cosyns P. Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings. Psychiatry Research: Neuroimaging 1993; 50:77-88.
13. Gilman A, Goodman L, Gilman A. The pharmacological basis of therapeutics New York: MacMillan, 1980.
14. Berman K Cortical stress tests in schizophrenia: regional cerebral blood flow studies. Biological Psychiatry 1987; 22:1304-1326.
15. De Lisi LE, Holcomb HH, Cohen RM et al. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism 1985; 5:201-206.
16. Berman KF, Doran AR, Pickar D, Weinberger DR. Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. British Journal of Psychiatry 1993; 162:183-192.
17. Weinberger DR, Berman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Archives of General Psychiatry 1988; 45:609-615.
18. Joyce EM. The relevance of recent advances in functional imaging to psychiatry. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55:427-430.
19. Gur RC, Erwin RJ, Gur RE. Neurobehavioural probes for physiologic neuroimaging studies. Archives of General Psychiatry 1992; 49:409-414.
20. Sergent J. Brain-imaging studies of cognitive functions. Trends in Neurosciences 1994; 17:221-227.
21. Ingvar D, Franzen G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatrica Scandinavica 1974; 50:425-427.
22. 15O positron emission tomographic scanning in predominantly never treated acute schizophrenic patients. Lancet 1983; Dec 24/31:1448-1452.
23. Volkow ND, Brodie J, Wolf AP, Angrist B, Russell J, Cancro R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. Journal of Neurology, Neurosurgery and Psychiatry 1986; 49:1199-1202.
24. Early TS, Reiman EM, Raichle ME, Spitznagel EL. Left globus pallidus abnormality in never medicated patients with schizophrenia. Proceedings of the National Academy of Sciences USA 1987; 84:561-563.
25. Wiesel FA, Wik G, Sjogren I, Blomqvist G, Greitz T, Stone Elander S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatrica Scandinavica 1987; 76:628-641.
26. Cleghorn JM, Garnett ES, Nahmias C et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Research 1989; 28:119-133.
27. Szechtman H, Nahmias C, Garnett S et al. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archives of General Psychiatry 1988; 45:523-532.
28. Chabrol H, Guell A, Bes A, Moron P. Cerebral blood flow in schizophrenic adolescents [letter]. American Journal of Psychiatry 1986; 143:130
29. Geraud M, Arne-Bes M, Guell A, Bes A. Reversibility of hemodynamic hypofrontality in schizphrenia. Journal of Cerebral Blood Flow and Metabolism 1987; 7:9-12.
30. Clark C, Klonoff H, Tyhurst J, Li D, Martin W, Pate B. Regional cerebral glucose metabolism in three sets of identical twins with psychotic symptoms. Canadian Journal of Psychiatry 1989; 34:263-270.
31. Hawton K, Shepstone B, Soper N, Reznek L. Single-photon emission computerised tomography (SPECT) in schizophrenia. British Journal of Psychiatry 1990; 156:425-427.
32. Buchsbaum MS, Haier RJ, Potkin SG et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry 1992; 49:935-942.
33. Rubin P, Holm S, Friberg L et al. Altered modulation of prefrontal and subcortical activity in newly diagnosed schizophrenia and schizophreniform disorder: a regional cerebral biood flow study. Archives of General Psychiatry 1991; 48:987-995.
34. Berman KF, Torrey EF, Daniel DG, Weinberger DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Archives of General Psychiatry 1992; 49:927-934.
35. Andreasen NC, Rezai K, Alliger R et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry 1992; 49:943-958.
36. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr et al. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. American Journal of Psychiatry 1993; 150:1325-1336.
37. Weinberger D, Berman K, Zec R. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow (rCBF) evidence. Archives of General Psychiatry 1986; 43:114-124.
38. Volkow ND, Wolf AP, Van Gelder P et al. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. American Journal of Psychiatry 1987; 144:151-158.
39. Lewis S, Ford R, Syed G, Reveley A, Toone B. A controlled study of 99mTc-HMPAO single photon emission imaging in chronic schizophrenia. Psychological Medicine 1992; 22:27-35.
40. Liddle PF, Friston KJ, Frith CD, Frackowiak RS. Cerebral blood flow and mental processes in schizophrenia. Journal of the Royal Society of Medicine 1992; 85:224-227.
41. Pardo JV, Pardo PJ, Janer KW, Raichle ME. The anterior cingulate mediates processing selection in the Stroop attentional conflict syndrome. Proceedings of the National Academy of Sciences USA 1990; 87:256-259.
42. Buchsbaum MS, Nuechterlein KH, Haier RJ et al. Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography. British Journal of Psychiatry 1990; 156:216-227.
43. Martinot J, Hardy P, Feline A et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. American Journal of Psychiatry 1990; 147:1313-1317.
44. Baxter L, Phelps M, Mazziotta J. Cerebral metabolic rates for glucose in mood disorders. Archives of General Psychiatry 1985; 42:441-447.
45. Ebert D, Feistel H, Barocka A. Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-HM-PAO. Psychiatry Research: Neuroimaging 1991; 40:247-251.
46. Mayberg H, Jeffery P, Wagner H, Simpson S. Regional cerebral blood flow in patients with depression measured with Tc-99m HMPAO SPECT (abstract). Journal of Nuclear Medicine 1991; 32:951.
47. Kling AC, Metter EJ, Riege WH, Kuhl DE. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry 1986; 143:175-180.
48. Buchsbaum M, De Lisi L, Holcomb H et al. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry 1984; 41:1159-1166.
49. Musalek M, Podreka I, Suess E et al. Neurophysiological aspects of auditory hallucinations: 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls - a preliminary report. Psychopathology 1988; 21:275-280.
50. Wolkin A, Jaeger J, Brodie J et al. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry 1985; 142:564-571.
51. DeLisi LE, Holcomb HH, Cohen RM et al. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism 1985; 5:201-206.
52. Rubin P, Holm S, Madsen PL et al. Regional cerebral blood flow distribution in newly diagnosed schizophrenia and schizophreniform disorder. Psychiatry Research 1994; 53:57-75.
53. Slater E, Beard AW, Glithero E. The schizophrenia like psychoses of epilepsy. British Journal of Psychiatry 1963; 109:95-150.
54. Roberts GW. Schizophrenia: a neuropathological perspective. British Journal of Psychiatry 1991; 158:8-17.
55. Fristen KJ, Liddle PF, Frith CD, Hirsch SR, Frackowiak RSJ. The medial temporal region in schizophrenia. A PET study Brain 1992; 115:367-382.
56. De Lisi LE, Buchsbaum MS, Holcomb HH et al. Increased temporal lobe glucose use in chronic schizophrenia. Biological Psychiatry 1989; 25:835-851.
57. Mathew R, Wilson W, Tant S, Robinson L, Prakash R. Abnormal resting regional blood flow patterns and their correlates in schizophrenia. Archives of General Psychiatry 1988; 45:542-549.
58. Matsuda H, Gyobu T, Hisada K. Iodine-123 iodoamphetamine brain scan in a patient with auditory hallucinations. Journal of Nuclear Medicine 1988; 29:558-560.
59. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry 1992; 160:179-186.
60. Notordonato H, Gonzalez-Avilez A, Van Heertum R, O'Connell RA, Yudd AP. The potential value of serial cerebral SPECT scanning in the evaluation of psychiatric illness. Clinical Nuclear Medicine 1989; 14.319-322.
61. Ebert D, Feistel H, Kaschka W. Left temporal hypoperfusion in catatonic syndromes Psychiatry Research: Neuroimaging 1992; 45:239-241.
62. Gordon E, Barry RJ, Anderson J et al. Single photon emission computed tomography (SPECT) measures of: brain function in schizophrenia. Australian and New Zealand Journal of Psychiatry 1994; 28:446-452.
63. Tamminga C, Thaker G, Buchanan R, Kirkpatrick B, Alphs L, Chase T, Carpenter W. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry 1992; 49:522-530.
64. Busatto GF, Costa DC, Ell PJ, Pilowsky LS, David AD, Kerwin RW. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99mTc-HMPAO single photon emission tomography (SPET) study. Psychological Medicine 1994; 24:463-472.
65. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Archives of General Psychiatry 1992; 49:975-982.
66. Goldman-Rakic PS, Friedman HR. The circuitry of working memory revealed by anatomy and metabolic imaging. In: Levin HS, Eisenberg HM, Benton AL, eds. Frontal lobe function and dysfunction. Oxford: Oxford University Press, 1991:72-91.
67. Sawaguchi T, Goldman-Rakic PS. The role of D1-dopamine receptor in working memory: local injections of dopamine anatagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed response task. Journal of Neurophysiology 1994; 71:515-528.
68. Erbas B, Kumbasar H, Erbengi G, Bekdik C. Tc-HMPAO/ SPECT determination of regional cerebral blood flow changes in schizophrenics. Clinical Nuclear Medicine 1990; 15:904-907.
69. Musalek M, Podreka I, Walter H et al. Regional brain function in hallucinations: a study of regional cerebral blood flow, with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations and normal controls. Comprehensive Psychiatry 1989; 30:99-108.
70. Andreasen N, Rezai K, Alliger R et al. Hypofrontality in neuroleptic naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single photon emission computed tomography and the Tower of London. Archives of General Psychiatry 1992; 49:943-958.
71. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry 1992; 49:959-965.
72. Farde L, Nordstrom AL. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. British Journal of Psychiatry Supplement 1992; 17:30-33.
73. Wong DF, Wagner HN Jr, Tune LE et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234:1558-1563. Erratum: Science 1987, 235:623.
74. 11C-raclopride. Psychopharmacology (Berlin) 1987; 92:278-284.
75. Andreasen NC, Carson R, Diksic M et al. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin 1988; 14:471-484.
76. 11C N-methylspiperone. Schizophrenia Research 1992; 22:147.
77. 11C-N-methylspiperone. Psychiatry Research 1993; 49:219-237.
78. Farde L, Pauli S, Stone-Elander S. D2 dopamine receptors in neuroleptic naive schizophrenic patients. Archives of General Psychiatry 1990; 47:213-219.
79. 76Br-bromospiperone in untreated schizophrenics. American Journal of Psychiatry 1990; 147:44-50.
80. 76Br-bromosiluride. British Journal of Psychiatry 1991; 158:346-350.
81. Hietala J, Syvalahti E, Vuorio K et al. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Archives of General Psychiatry 1994; 51:116-123.
82. 123I-BZM single photon emission computerised tomography study. British Journal of Psychiatry 1994; 164:16-26.
83. Pycock CJ, Kerwin RJ, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical receptors in rats. Nature 1980; 286:74-77.
84. Christie MJ, Rows PJ, Bernt PM. Effect of excitotoxin lesions in the medical prefrontal cortex on cortical and subcortical catecholamine turnover in the rat. Journal of Neurochemistry 1986; 47:1593-1597.
85. Grace AA. Phasic versus tonic dopomine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991; 41:1-24.
86. Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 1992; 7:261-264.
87. Seeman P, Guan H, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365:441-445.
88. Van Tol HH, Bunzow JR, Guan HC et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350:610-614.
89. Lewine RR, Gulley LR, Risch SC, Jewart R, Houpt JL. Sexual dimorphism, brain morphology and schizophrenia. Schizophrenia Bulletin 1990; 16:195-203.
90. Flor-Henry P. Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophrenia Bulletin 1990; 16:211-227.
91. Castle DJ, Murray RM. The neurodevelopmental basis of sex differences in schizophrenia. Psychological Medicine 1991; 21:565-575.
92. Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry 1988; 45:71-76.
93. Baron JC, Marinot JL, Cambon H et al. Stnatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 1989; 99:463-472.
94. 18F]N-methyl-spiroperidol PET studies to measure changes in antipsychotic drug D2 receptor occupancy in schizophrenic patients. Biological Psychiatry 1988; 23:653-663.
95. Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NPL, Kerwin RW. Clozapine, single photon emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 1992; 340:199-202.
96. Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988; 45:789-796.
97. Coppens HJ, Slooff CJ, Paans AMJ, Wiegman T, Vaalburg W, Korf J. High central D2 dopamine receptor occupancy as assessed with positron emission tomography in medicated but treatment resistant schizophrenic patients. Biological Psychiatry 1991; 29:629-634.
98. Wolkin A, Barouche F, Wolf AP et al. Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. American Journal of Psychiatry 1989; 146:905-908.
99. 123I-iodobenzamide in chronic schizophrenia. Psychiatry Research: Neuroimaging 1994; 55:111-118.
100. Dean B, Copolov DL. Dopamine receptors, Australian Journal of Psychopharmacology 1994, 7:10-15.
101. Waddington JL, O'Callaghan E, Larkin C, Redmond O, Stack J, Ennis JT. Magnetic resonance imaging and spectroscopy in schizophrenia. British Journal of Psychiatry Supplement 1990:56-65.
102. Guze BH. Magnetic resonance spectoscopy. A technique for functional imaging. Archives of General Psychiatry 1991; 48:572-574.
103. Kershavan MS, Pettegrew JW, Panchalingam K, Kaplan D, Brar J, Campbell K. In vivo 31-P magnetic resonance (NMR) spectroscopy of the frontal lobe metabolism in neuroleptic naive first episode psychoses: preliminary studies. Schizophrenia Research 1989; 2:122.
104. Pettegrew JW, Keshavan MS, Panchalingam K et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy [see comments]. Archives of General Psychiatry 1991; 48:563-568.
105. Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls [letter; comment]. Archives of General Psychiatry 1991; 48:578.
106. 31P magnetic resonance spectroscopy of the left temporal lobe in schizophrenia: procedures and preliminary results. Schizophrenia Research 1989, 2:125.
107. Calabrese G, Deicken RF, Fein G, Metrin EL, Schoenfeld F, Weiner MW. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry 1992; 32:26-32.
108. Williamson PC. Schizophrenia as a brain disease. Archives of Neurology 1993; 50:1096-1097.
109. Stanley JA, Williamson PC, Drost DJ, Carr I, Rylett J, Merskey H. In vivo proton MRS in never treated schizophrenics. Proceedings of the American Psychiatric Association 1992:50.
110. David A, Blamire A, Breiter H. Functional magnetic resonance imaging. A new technique with implications for psychology and psychiatry. British Journal of Psychiatry 1994; 164:2-7.
111. Cohen MS, Bookheimer SY. Localization of brain function using magnetic resonance imaging. Trends in Neurosciences 1994; 17:268-277.